U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg has announced her plans to step down at the end of March 2015.
Dr. Hamburg’s six-year tenure at the FDA included the controversial decision to approve the emergency contraceptive Plan B One-Step® for use without a prescription by teenage girls.
Dr. Stephen Ostroff will serve as Acting Commissioner after Dr. Hamburg’s departure.
An announcement is posted on the FDA website here.